Artisan Partners
ALNY icon

Artisan Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Artisan Partners’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-117,345
Closed -$19.2M – 319
2022
Q1 		$19.2M Sell
117,345
-121,791
-51% -$18.6M 0.03% 288
2021
Q4 		$40.6M Sell
239,136
-3,648
-2% -$678K 0.05% 262
2021
Q3 		$45.8M Buy
242,784
+4,202
+2% +$788K 0.06% 248
2021
Q2 		$40.4M Buy
238,582
+10,394
+5% +$1.52M 0.05% 260
2021
Q1 		$32.2M Buy
228,188
+28,015
+14% +$4.22M 0.04% 289
2020
Q4 		$26M Buy
200,173
+36,481
+22% +$4.87M 0.03% 288
2020
Q3 		$23.8M Buy
163,692
+36,867
+29% +$5.24M 0.03% 278
2020
Q2 		$18.8M Buy
126,825
+20,599
+19% +$2.78M 0.03% 267
2020
Q1 		$11.6M Buy
+106,226
New +$12.3M 0.02% 260
2016
Q4 		– Sell
-221,733
Closed -$15M – 260
2016
Q3 		$15M Sell
221,733
-3,470
-2% -$245K 0.03% 231
2016
Q2 		$12.5M Sell
225,203
-8,456
-4% -$533K 0.03% 230
2016
Q1 		$14.7M Sell
233,659
-4,364
-2% -$290K 0.03% 235
2015
Q4 		$22.4M Sell
238,023
-6,881
-3% -$638K 0.04% 217
2015
Q3 		$19.7M Sell
244,904
-774,376
-76% -$86M 0.04% 221
2015
Q2 		$122M Sell
1,019,280
-65,280
-6% -$7.8M 0.23% 136
2015
Q1 		$113M Buy
1,084,560
+793,178
+272% +$80.4M 0.2% 142
2014
Q4 		$28.3M Sell
291,382
-256,474
-47% -$23.8M 0.05% 233
2014
Q3 		$42.8M Sell
547,856
-27,002
-5% -$1.74M 0.08% 201
2014
Q2 		$36.3M Buy
574,858
+55,975
+11% +$3.33M 0.06% 230
2014
Q1 		$34.8M Buy
518,883
+75,161
+17% +$5.82M 0.06% 235
2013
Q4 		$28.5M Buy
443,722
+20,899
+5% +$1.25M 0.05% 242
2013
Q3 		$27.1M Buy
+422,823
New +$21.1M 0.05% 250

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners's ALNY Position: Q2 2022 in Review

Artisan Partners sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2022, closing a stake of 117,345 shares — an estimated $19.2M sold.

Artisan Partners first reported a position in ALNY in Q3 2013 and held it in 22 quarters. The position peaked at $122M in Q2 2015. 421 funds tracked by Wall St. Rank hold ALNY as of Q2 2022.

  • Artisan Partners reported no remaining Alnylam Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Artisan Partners sold 117,345 Alnylam Pharmaceuticals shares in Q2 2022, an estimated $19.2M.
  • Artisan Partners first reported a position in Alnylam Pharmaceuticals in Q3 2013 and held it in 22 quarters.
  • Artisan Partners's Alnylam Pharmaceuticals position peaked at $122M in Q2 2015.
  • 421 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2022.

Based on Artisan Partners's 13F filing for Q2 2022, filed 12 Aug 2022.